Abstract
Background
Recently, several randomized and controlled trials have demonstrated great advantages of a drug‐eluting stent (DES) with respect to significant reduction in restenosis and recurrence of symptoms, and improvement in clinical outcomes after percutaneous coronary intervention (PCI). Little is known about the comparative effects of the 1‐DES plus the kissing balloon technique with the 2‐DES for bifurcation angioplasty in a Chinese population.
Methods
From April 2004 to June 2006, 566 consecutive Chinese patients underwent DES implantation for true bifurcation lesions, including 346 1‐DES with the kissing balloon technique (300 male, 57.7 ± 11.5 y old) and 220 2‐DES (183 male, 58.1 ± 10.7 y old) were analyzed. Clinical and angiographic follow‐up was performed after 7 mo.
Results
The major adverse cardiac event (MACE) rates were higher in the 2‐DES group than in the 1‐DES group (5.5% versus 2.0%; p = 0.032), which was mainly contributed to by acute myocardial infarction (AMI) (4.5% versus 1.4%; p = 0.032), rather than death and target lesion revascularization (TLR) (0% versus 0.5%; p = 0.389, 1.4% versus 2.7%; p = 0.352). Stent thrombosis rates were higher in the 2‐DES group than in the 1‐DES group (0.6% versus 2.7%; p = 0.042), except for 1 late‐stent thrombosis in the 2‐DES group, and all of them were subacute stent thrombosis (2 in the 1‐DES group and 5 in the 2‐DES group). The 7 mo angiographic follow‐up rate was 36.4%. In the main branch there was no difference in restenosis rate in the 1‐DES group compared with the 2‐DES group (9.8% versus 11.9%; p = 0.652), but in the side branch the restenosis rate was higher in the 1‐DES group (33.6% versus 15.5%; p = 0.004). However, there was no difference in in‐segment late loss between the 2 groups, either in the main or side branch.
Conclusion
Compared with the 2‐DES strategy, if a final kissing balloon could be achieved, the 1‐DES strategy may be more efficient and safe. Copyright © 2008 Wiley Periodicals, Inc.
Keywords: percutaneous coronary intervention, drug eluting stent, bifurcation
Full Text
The Full Text of this article is available as a PDF (101.0 KB).
References
- 1. George BS, Myler RK, Stertzer SH, Clark DA, Cote G, et al.: Balloon angioplasty of coronary bifurcation lesions: the kissing balloon technique. Cathet Cardiovasc Diagn 1986; 12: 124–138. [DOI] [PubMed] [Google Scholar]
- 2. Lefevre T, Louvard Y, Morice MC, Dumas P, Loubeyre C, et al.: Stenting of bifurcation lesions: classification, treatments, and results. Catheter Cardiovasc Interv 2000; 49: 274–283. [DOI] [PubMed] [Google Scholar]
- 3. Sheiban I, Albiero R, Marsico F, Dharmadhikari A, Tzifos V, et al.: Immediate and long‐term results of “T” stenting for bifurcation coronary lesions. Am J Cardiol 2000; 85: 1141–1144 A9. [DOI] [PubMed] [Google Scholar]
- 4. Karvouni E, Di Mario C, Nishida T, Tzifos V, Reimers B, et al.: Directional atherectomy prior to stenting in bifurcation lesions: a matched comparison study with stenting alone. Catheter Cardiovasc Interv 2001; 53: 12–20. [DOI] [PubMed] [Google Scholar]
- 5. Yamashita T, Nishida T, Adamian MG, Briguori C, Vaghetti M, et al.: Bifurcation lesions: two stents versus one stent: immediate and follow‐up results. J Am Coll Cardiol 2000; 35: 1145–1151. [DOI] [PubMed] [Google Scholar]
- 6. Al Suwaidi J, Berger PB, Rihal CS, Garratt KN, Bell MR, et al.: Immediate and long‐term outcome of intracoronary stent implantation for true bifurcation lesions. J Am Coll Cardiol 2000; 35: 929–936. [DOI] [PubMed] [Google Scholar]
- 7. Colombo A, Moses JW, Morice MC, Ludwig J, Holmes DR, et al.: Randomized study to evaluate sirolimus‐eluting stents implanted at coronary bifurcation lesions. Circulation 2004; 109: 1244–1249. [DOI] [PubMed] [Google Scholar]
- 8. Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, et al.: SIRIUS Investigators: Sirolimus‐eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 2003; 349: 1315–1323. [DOI] [PubMed] [Google Scholar]
- 9. Lefevre T, Louvard Y, Morice MC, Dumas P, Loubeyre C, et al.: Stenting of bifurcation lesions: classification, treatments, and results. Catheter Cardiovasc Interv 2000; 49: 274–283. [DOI] [PubMed] [Google Scholar]
- 10. Ellis SG, Vandormael MG, Cowley MJ, DiSciascio G, Deligonul U, et al.: Coronary morphologic and clinical determinants of procedural outcome with angioplasty for multivessel coronary disease. Implications for patient selection. Multivessel angioplasty prognosis study group. Circulation 1990; 82: 1193–1202. [DOI] [PubMed] [Google Scholar]
- 11. Louvard Y, Lefevre T, Morice MC: Percutaneous coronary intervention for bifurcation coronary disease. Heart 2004; 90: 713–722. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12. Pan M, de Lezo JS, Medina A, Romero M, Segura J, et al.: Rapamycin‐eluting stents for the treatment of bifurcated coronary lesionsa randomized comparison of a simple versus complex strategy. Am Heart J 2004; 148: 857–864. [DOI] [PubMed] [Google Scholar]
- 13. Glagov S, Zarins C, Giddens DP, Ku DN: Hemodynamics and atherosclerosis. Insights and perspectives gained from studies of human arteries. Arch Pathol Lab Med 1988; 112: 1018–1031. [PubMed] [Google Scholar]
- 14. Honda Y, Fitzgerald PJ: Stent thrombosisan issue revisited in a changing world. Circulation 2003; 108: 2–5. [DOI] [PubMed] [Google Scholar]
- 15. Farb A, Burke AP, Kolodgie FD, Virmani R: Pathological mechanisms of fatal late coronary stent thrombosis in humans. Circulation 2003; 108: 1701–1706. [DOI] [PubMed] [Google Scholar]
- 16. Virmani R, Guagliumi G, Farb A, Musumeci G, Grieco N, et al.: Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus‐eluting stentshould we be cautious? Circulation 2004; 109: 701–705. [DOI] [PubMed] [Google Scholar]
- 17. Iakovou I, Schmidt T, Bonizzoni E, Ge L, Sangiogi GM, et al.: Incidence, predictors, and outcome of thrombosis after successful implantation of drug‐eluting stents. JAMA 2005; 293: 2126–2130. [DOI] [PubMed] [Google Scholar]
- 18. Steigen TK, Maeng M, Wiseth R: Randomized study on simple versus complex stenting of coronary artery bifurcation lesions‐the nordic bifurcation study. Circulation 2006; 114: 1955–1961. [DOI] [PubMed] [Google Scholar]
